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Abstract
A broad range of redox-regulated proteins undergo reversible disulfide bond formation on 
oxidation-prone cysteine residues. Heightened reactivity of the thiol groups in these cysteines also 
increases susceptibility to modification by organic electrophiles, a property that can be exploited 
in the study of redox networks. Here, we explored whether divinyl sulfone (DVSF), a thiol-
reactive bifunctional electrophile, cross-links oxidant-sensitive proteins to their putative redox 
partners in cells. To test this idea, previously identified oxidant targets involved in oxidant defense 
(namely, peroxiredoxins, methionine sulfoxide reductases, sulfiredoxin, and glutathione 
peroxidases), metabolism, and proteostasis were monitored for cross-link formation following 
treatment of Saccharomyces cerevisiae with DVSF. Several proteins screened, including multiple 
oxidant defense proteins, underwent intermolecular and/or intramolecular cross-linking in 
response to DVSF. Specific redox-active cysteines within a subset of DVSF targets were found to 
influence cross-linking; in addition, DVSF-mediated cross-linking of its targets was impaired in 
cells first exposed to oxidants. Since cross-linking appeared to involve redox-active cysteines in 
these proteins, we examined whether potential redox partners became cross-linked to them upon 
DVSF treatment. Specifically, we found that several substrates of thioredoxins were cross-linked 
to the cytosolic thioredoxin Trx2 in cells treated with DVSF. However, other DVSF targets, like 
the peroxiredoxin Ahp1, principally formed intra-protein cross-links upon DVSF treatment. 
Moreover, additional protein targets, including several known to undergo S-glutathionylation, were 
conjugated via DVSF to glutathione. Our results indicate that DVSF is of potential use as a 
chemical tool for irreversibly trapping and discovering thiol-based redox partnerships within cells.
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Introduction
Elevated levels of oxidants play a key role in pathogen defense, development, and 
degeneration associated with aging and numerous age-related diseases [1-3]. The reactive 
oxygen species (ROS) formed during these processes oxidize a variety of molecular targets, 
including DNA, lipids, and proteins, thereby leading to alterations in cellular homeostasis 
and, when damage is pronounced, cellular dysfunction and death [4, 5]. Protein targets of 
ROS are commonly modified on specific cysteine residues that contribute to the protein’s 
function [6-8]. A cysteine residue’s susceptibility to oxidation is influenced by many factors, 
including its accessibility and an appropriate microenvironment that lowers its thiol pKa to 
form a thiolate [8, 9]. Following oxidation of a cysteine thiolate to a sulfenic acid, the 
sulfenic acid can react with another thiol in a protein or in glutathione to form a disulfide 
bond or may, in some instances, condense with the peptide backbone to form a sulfenamide 
[10]; such modifications are reversible by thiol reductases (e.g., thioredoxins, glutaredoxins) 
[11]. However, more extensive oxidation of cysteine thiols to sulfinic acids is considered 
largely irreversible [10]. Cysteine sulfinic acids are thought to undergo reduction only in a 
subset of peroxiredoxins that are recognized and repaired by sulfiredoxins [12].
Because cysteine oxidation often serves as a regulatory post-translational modification, 
considerable attention has been focused on identifying oxidation-prone proteins within the 
proteome [13, 14]. Proteome-wide screens have revealed a number of proteins undergoing 
sulfenylation, S-glutathionylation, and disulfide formation [15-22], as well as proteins that 
are redox partners of thioredoxins [23-28]. The proteins identified from these studies 
participate in a variety of cellular processes, including oxidant defense, metabolism, gene 
expression, maintenance of cell structure, and proteostasis. Although distinct networks of 
proteins that partner in oxidant defense and other processes have emerged from this work, 
the redox partnerships in certain cases have not been fully elucidated, indicating a need for 
alternative methodological approaches to establish such relationships.
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Many of the same protein targets of ROS are prone to alkylation by thiol-targeted 
electrophiles, due to the heightened reactivity and accessibility of their oxidation-prone 
cysteines [29, 30]. Indeed, there is overlap between the proteins identified as oxidant and 
electrophile targets in many species [31]. For example, oxidant-defense proteins that employ 
Cys-based mechanisms for peroxide detoxification and disulfide reduction exhibit 
heightened reactivity toward numerous thiol-reactive electrophiles [32-38]. Moreover, work 
from our laboratory and others has revealed that several proteins which participate in a 
prominent oxidant defense relay involving peroxiredoxins, thioredoxins, and thioredoxin 
reductases undergo cross-linking to one another at their redox centers following exposure to 
homobifunctional electrophiles [39-42]. Cross-linking of these partners in Saccharomyces 
cerevisiae was particularly pronounced with the bifunctional electrophile divinyl sulfone 
(DVSF) [39].
Based on our earlier findings, we explored whether DVSF, due to its small size and 
irreversible reactivity with thiols, traps redox-active cysteine pairs that normally undergo 
reversible disulfide formation in oxidant-sensitive proteins. To this end, we tested whether a 
panel of oxidation-prone proteins underwent cross-linking in S. cerevisiae upon treatment 
with DVSF. Several of the DVSF target proteins that we identified formed cross-links with 
thioredoxins (their proposed intracellular reductant), whereas others formed intra-protein 
cross-links or were conjugated through DVSF to glutathione (GSH). Such a chemical 
approach may be useful in characterizing novel redox partnerships in and between proteins 
across a broad range of species.
Materials and Methods
Cloning and Mutagenesis of Candidate Genes
S. cerevisiae genes encoding oxidant-sensitive proteins were amplified from genomic DNA 
using standard PCR procedures and primers indicated in Supplementary Table 1. FLAG tags 
were incorporated at the N-terminus for most proteins. C-terminal FLAG tags were 
incorporated into proteins localized to mitochondria (i.e., Prx1 and Mxr2) or when poor 
expression was observed with the N-terminal tag (i.e., Mxr1). PCR products were subjected 
to restriction digestion with the appropriate restriction enzymes and ligated into the yeast 
expression vector p416-GPD or the bacterial protein expression vector pET45b (Novagen) 
using standard molecular techniques. Cloning was verified by restriction analysis and DNA 
sequencing of the full gene. Site-directed mutagenesis of genes encoding DVSF targets was 
performed by PCR with mutagenic primers and DpnI digestion of the template vector as 
described in the QuikChange PCR Method (Agilent). Primers used for site-directed 
mutagenesis are included in Supplementary Table 2. All mutations were confirmed by DNA 
sequencing.
S. cerevisiae Strains and Culture
Yeast strains used in this study are described in Supplementary Table 3. A strain lacking 
cytosolic thioredoxins (trx1Δ trx2Δ or trxΔ) was generated by disrupting the TRX2 locus 
with a HIS3 cassette in the trx1Δ strain from the yeast deletion library (Open Biosystems). 
All deletion strains were genotyped by PCR and analyzed for peroxide sensitivity. BY4741 
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and gsh1Δ strains were maintained in YPD culture medium, which has adequate GSH for 
survival of the gsh1Δ strain [43]. Strains expressing FLAG-tagged proteins (encoded by the 
corresponding p416-GPD clones) were maintained in synthetic complete medium lacking 
uracil (SC-Ura) containing 2% (w/v) glucose (Sunrise Science).
Cell Treatment, Protein Lysis, and Western Blotting to Detect DVSF-Mediated Cross-
Linking
Cells grown to mid-log phase were treated with DVSF (Sigma) for 1 h at 30°C. In some 
experiments, cells were pre-incubated with H2O2 (Sigma) or tert-butylhydroperoxide 
(TBHP, Sigma). Cells were lysed by vortexing with acid-washed glass beads in a buffer 
containing 20 mM Tris-HCl (pH 8.0), 0.5 mM Na2EDTA, 10% glycerol, 50 mM NaCl, and a 
protease inhibitor cocktail as described previously [39]. Protein concentrations in lysates 
were determined using a Bradford assay (Sigma) with bovine serum albumin (Pierce) as a 
standard. Lysates were resolved on SDS-PAGE under reducing conditions and transferred to 
polyvinyl difluoride membrane. Membranes were blocked with TBS-T buffer (100 mM Tris-
HCl (pH 7.5), 150 mM NaCl, and 0.1% (v/v) Tween 20) containing 5% (w/v) non-fat dry 
milk. Membranes were incubated with primary antibodies against the FLAG tag (M2, mouse 
monoclonal, Sigma), Pgk1 (mouse monoclonal, Invitrogen), glutathione (mouse 
monoclonal, Santa Cruz), protein A (which detects a tandem affinity purification (TAP) tag; 
rabbit polyclonal, Sigma), and green fluorescent protein (GFP, rabbit polyclonal, Invitrogen) 
at 4°C overnight. Subsequently, membranes were washed three times for 10 min with TBS-
T, exposed to appropriate horseradish peroxidase-linked secondary antibodies (Cell 
Signaling Technologies) for 45 min, washed with TBS-T four times for 15 min, and 
visualized with chemiluminescent detection.
Immunoprecipitation of FLAG-Tagged Proteins
The immunoprecipitation procedure was adapted from a procedure described previously 
[39]. Briefly, protein lysates from DVSF-treated yeast cultures (100 μg) were diluted in lysis 
buffer to 600 μL and subjected to immunoprecipitation with 8 μL EZView anti-FLAG beads 
(Sigma) on a tube rotator for 4 h at 4°C. Beads were pelleted and washed six times with lysis 
buffer (20 mM Tris-HCl (pH 8.0), 0.5 mM Na2EDTA, 10% glycerol, 50 mM NaCl) 
supplemented with 0.1% (w/v) SDS and 0.5% (w/v) sodium deoxycholate. Elution of 
immunoprecipitated proteins was carried out at room temperature for 30 min with 0.5 
mg/mL 3X FLAG peptide dissolved in a buffer containing 50 mM Tris-HCl (pH 7.5) and 
150 mM NaCl. The supernatant containing the eluant was recovered and subjected to 
analysis by Western blot with the indicated antibodies.
Purification of Ahp1 Interface and Active Site Mutants
pET45b-Ahp1 expression constructs were transformed into Rosetta DE3 cells (Novagen). 
Cultures of transformants were grown at 37°C to mid-log phase in 400 mL LB broth 
containing 100 μg/mL ampicillin, prior to induction for 6 h at 37°C with 1 mM isopropyl β-
D-thiogalactopyranoside. Cells were pelleted, and His-tagged proteins were purified using a 
Fast Start Ni-NTA kit (Qiagen) according to manufacturer’s instructions. Eluted proteins 
were desalted on a PD25 Sephadex gel filtration column (GE Healthcare) equilibrated with 
50 mM Tris-HCl (pH 7.5), 2 mM DTT, 10% glycerol, and protease inhibitor cocktail (G 
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Biosciences) and, upon confirming purity by SDS-PAGE, frozen at −80°C. Proteins were 
quantified at A280 using an estimated extinction coefficient of 37,930 M−1•cm−1 (http://
web.expasy.org/protparam/).
Analysis of Ahp1 Variant Proteins
To evaluate oligomeric states, purified Ahp1 dimer interface mutants (20 μM) were resolved 
on 4-16% Bis-Tris native PAGE gels (Invitrogen) run at 150 V. Following electrophoresis, 
proteins were detected by staining with Coomassie blue. For cross-linking experiments with 
purified Ahp1, recombinant proteins were reduced with 20 mM DTT at 37°C for 1 h prior to 
desalting on a BioSpin6 column (Biorad) equilibrated with 50 mM HEPES-OH (pH 8.0). 
Protein cross-linking reactions (20 μL) were carried out with 10 μM purified protein, 50 mM 
HEPES-OH (pH 8.0), 150 mM NaCl, 2.5 mM Na2EDTA, and varying doses of DVSF (or 
DMSO, vehicle control) for 3 h at 37°C. Reactions were quenched by boiling in reducing 
SDS-PAGE sample buffer prior to resolution by SDS-PAGE. Proteins were visualized with 
Coomassie blue. To monitor S-glutathionylation in Ahp1 bearing individual cysteine to 
alanine substitutions, purified recombinant proteins were reduced with 20 mM DTT at 37°C 
for 1 h prior to desalting on a BioSpin6 column equilibrated with 50 mM Tris-HCl (pH 8.0). 
Protein cross-linking reactions (20 μL) were carried out with 10 μM purified protein, 50 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 2.5 mM Na2EDTA, and varying doses of oxidized GSH 
(GSSG) for 20 min at 37°C. Reactions were terminated by incubation with 10 mM N-
ethylmaleimide for 10 min at 37°C. Proteins were denatured by boiling in non-reducing 
SDS-PAGE sample buffer prior to resolution by SDS-PAGE. S-glutathionylation was 
detected by Western blot; protein loading and intersubunit disulfide formation were 
visualized with Coomassie blue.
Toxicity Assays with tert-Butyl Hydroperoxide
Cultures of BY4741 or ahp1Δ transformed with empty vector (p416-GPD) or Ahp1 
expression constructs were grown overnight in uracil-dropout medium to saturation at 30°C. 
Yeast cultures were diluted to an OD600 of 0.5, from which 10-fold serial dilutions were 
prepared. Dilutions were plated onto YPD medium lacking or containing 2 mM TBHP. 
Plates were incubated at 30°C for 48 h prior to growth analysis to measure peroxide 
sensitivity.
Results
Cross-Linking of Oxidation-Prone Proteins in Cells Treated with DVSF
Previously, we reported that DVSF cross-links the cytosolic thioredoxin Trx2 to two of its 
major redox partners, thioredoxin reductase (Trr1) and an abundant 2-Cys peroxiredoxin 
(Tsa1) in S. cerevisiae [39]. Based on these results, we hypothesized that other oxidation-
prone proteins undergo DVSF-mediated cross-linking to potential redox partners. To test this 
hypothesis, we screened a panel of 19 oxidant-sensitive FLAG-tagged proteins that 
participate in a number of different cellular processes (oxidant defense (peroxiredoxins, 
methionine sulfoxide reductases, sulfiredoxin, and glutathione peroxidases), metabolism, 
and proteostasis) [17, 19, 21]. We monitored whether each of these proteins underwent a 
molecular weight shift (indicative of cross-linking) when isolated from cells treated with a 
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cytotoxic dose of DVSF [44, 45]. Under these conditions, each cytosolic peroxiredoxin 
(Tsa1, Tsa2, and Ahp1), each methionine sulfoxide reductase (Mxr1, Mxr2, and Ykg9), 
sulfiredoxin (Srx1), a glutathione peroxidase (Gpx1), isopropylmalate isomerase (Leu1), and 
ribonucleotide reductase (Rnr1) formed intermolecular cross-links, as detected by the 
migration of proteins at a higher molecular weight when compared with the unmodified, 
monomeric form (Fig. 1). In addition, a fraction of the Mxr1, Ykg9, Gpx2, and Gpx3 
expressed electrophoresed more quickly in lysates from cells treated with DVSF (Fig. 1), 
suggesting that an intramolecular cross-link forms in these proteins similar to what has been 
observed with intramolecular disulfide formation [46, 47]. Several proteins, including a 
mitochondrial peroxiredoxin (Prx1), a nuclear peroxiredoxin (Dot5), a glyceraldehyde-3-
phosphate dehydrogenase (Tdh3), a ribosomal small subunit protein (Rps5), two molecular 
chaperones (Sse1 and Ssa1), and an ubiquitin-conjugating enzyme (Ubc1), did not undergo 
appreciable molecular weight changes upon DVSF treatment, indicating that they may not 
be readily cross-linked to other proteins or internally cross-linked under these conditions. 
Therefore, we focused most of our subsequent work on proteins that underwent pronounced 
molecular weight shifts upon treatment with DVSF.
DVSF-Mediated Cross-Linking through Modification of Redox-Active Thiols
To ascertain whether redox-active cysteines are responsible for cross-linking, we introduced 
individual alanine substitutions at all cysteine residues in the primary sequence for several of 
the proteins we identified as DVSF targets. In Ahp1, substitution of either the resolving or 
the peroxidatic cysteine (Cys31 and Cys62, respectively) to alanine prevented cross-linking 
by DVSF (Fig. 2), implying that the principal redox-active cysteine residues in the active site 
were modified by DVSF [48]. Likewise, alanine substitutions of the primary catalytic 
residues in Srx1 (Cys84) and Gpx3 (Cys36 and Cys82) decreased cross-linking with DVSF 
(Fig. 2) [46, 49, 50]. In the case of Ykg9, an internal redox relay involving Cys91, Cys101, 
and Cys125 has been proposed, with Cys125 playing a key role in catalysis [51, 52]. While 
the cross-linking patterns with Ykg9 mutants were more complex, internal cross-linking of 
Ykg9 by DVSF was decreased when Cys125 was changed to Ala (Supp. Fig. 1). To provide 
further support that the redox-active cysteines of DVSF targets are involved in cross-linking, 
we tested whether a subset of these proteins undergo cross-linking in cells first treated with 
oxidants (either H2O2 or TBHP, an organic peroxide and preferential substrate for Ahp1 
[48]). Pre-incubation of cells with peroxides decreased DVSF-mediated cross-linking of 
Tsa1, Srx1, and Ahp1 (Fig. 3), suggesting that they are incapable of reacting with DVSF 
when in their oxidized forms. Collectively, these results suggest that DVSF modifies key 
oxidation-prone cysteine residues in its target proteins to promote cross-linking.
Stabilizing Interactions between Proteins Involved in Redox Networks with DVSF
Previously, we found that Trx2 formed cross-linked complexes with known redox partners, 
Tsa1 and Trr1, following treatment of cells with DVSF [39]. Since both Tsa1 and Trr1 are 
abundant proteins [53], we sought to determine whether other low-abundance Trx2 
interaction partners–in this case, other Trx2 substrates–undergo cross-linking to Trx2 when 
exposed to DVSF (Fig. 4A). Several of the proteins that formed intermolecular cross-links 
upon treatment with DVSF in our initial screen were expressed in a yeast strain lacking the 
two cytosolic thioredoxins (trx1Δ trx2Δ, labeled as trxΔ). When these strains were treated 
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with DVSF, we observed that Tsa1, Tsa2, and Ykg9 formed fewer cross-linked species 
compared with the wild-type control (BY4741) (Fig. 4B), suggesting that thioredoxins 
potentially form one or more cross-linked complexes with these substrates in cells treated 
with DVSF. Likewise, Srx1, which interacts with both cytosolic peroxiredoxins (Tsa1 and 
Tsa2) and thioredoxins (Trx1 and Trx2), exhibited differential DVSF cross-linking patterns 
with protein targets in both trx1Δ trx2Δ and tsa1Δ tsa2Δ (labeled as tsaΔ) backgrounds, 
implying that these proteins become cross-linked to Srx1 upon DVSF treatment. To further 
support our findings, the FLAG-tagged proteins were co-expressed in a strain containing a 
TAP-tagged Trx2 (Trx2-TAP) for co-immunoprecipitation experiments. Following treatment 
of these strains with DVSF, Trx2-TAP co-immunoprecipitated in cross-linked complexes 
with FLAG-tagged Tsa1, Tsa2, Ykg9, and Srx1 (Fig. 4C). Moreover, complexes of cross-
linked Tsa1 which resolved at a similar molecular weight as some Srx1 complexes were 
isolated upon immunoprecipitation of Srx1 (Supp. Fig. 2). While we were able to isolate 
cross-linked complexes of Trx2 with particular substrates, not all DVSF targets studied (e.g., 
Ahp1) underwent extensive cross-linking with Trx2, despite being known substrates for 
thioredoxins (Supp. Fig. 3). The latter result prompted us to examine other potential redox 
partners, including cysteine redox pairs within an individual protein’s structure and small 
molecule thiols like GSH, that might become cross-linked to these proteins in lieu of 
thioredoxin upon DVSF treatment.
Studying Redox Centers within Individual Proteins with DVSF
Since the two cysteine residues that form an intersubunit disulfide bond in Ahp1 (Cys31 and 
Cys62) are also required for cross-linking by DVSF (Fig. 2), we sought to disrupt this 
natural redox pairing in the protein by decreasing dimer formation. Two conserved 
phenylalanine residues (Phe58 and Phe95) reside at the interface of the Ahp1 dimer (Fig. 
5A, Supp. Fig. 4) [48]. We hypothesized that these residues allow for hydrophobic and 
aromatic stacking interactions to promote dimer assembly. Therefore, Phe58 and Phe95 were 
mutated to alanine or leucine to investigate a potential link between Ahp1 oligomerization 
and cellular protection against organic peroxides. Upon substitution of both Phe58 and 
Phe95 to either alanine or leucine, purified recombinant Ahp1 exhibited decreased subunit 
dimerization by native PAGE, whereas dimer disruption was less pronounced with individual 
mutations at these sites (Fig. 5B, Supp. Fig. 5A). Alterations of these aromatic residues, 
especially when introduced in tandem, compromised Ahp1’s ability to protect against TBHP 
when expressed in an ahp1-deficient (ahp1Δ) background (Fig. 5C, Supp. Fig. 5B), 
suggesting that Phe58 and Phe95 collectively play a structural role in dimer formation and 
are critical for the protein’s function in cells. Using the Ahp1 interface mutants, we tested 
whether the protein undergoes inter-subunit cross-linking with DVSF (Fig. 5D). Combined 
substitution of Phe58 and Phe95 to alanine or leucine at the dimer interface decreased inter-
subunit cross-linking of purified Ahp1 by DVSF in vitro (Fig. 5E, Supp. Fig. 5C). Likewise, 
these mutant Ahp1 proteins were cross-linked less readily by DVSF in cells (Fig. 5F, Supp. 
Fig. 5D). Collectively, these results suggest a correlation between the oligomeric state of 
Ahp1 and susceptibility to DVSF-mediated intersubunit cross-linking, but they do not rule 
out the possibility that shifting Ahp1 toward a monomeric state influences the reactive 
nature of its active site cysteines and thereby limits peroxide clearance and electrophilic 
modification. On a more general level, however, our studies with the Ahp1 dimer indicate 
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that DVSF has utility in probing pairs of redox-active Cys residues within individual 
proteins in cells.
Exploring Putative Glutathionylation Targets with DVSF
While some proteins form intermolecular disulfide bonds with other thiol oxidoreductases 
(e.g., thioredoxins), many proteins also undergo reversible redox chemistry with small 
molecule thiols like GSH [54]. Therefore, we explored whether DVSF could be used to 
detect GSH conjugates of several proteins that are prone to S-glutathionylation during 
oxidative stress (Fig. 6A). We found that protein-GSH conjugates increased in a dose-
dependent fashion following DVSF treatment (Fig. 6B). In yeast lacking the ability to 
synthesize GSH de novo (gsh1Δ) [43], GSH underwent adduction to fewer proteins in the 
presence of DVSF (Fig. 6C). Moreover, several yeast proteins with mammalian orthologs 
that are susceptible to regulation by glutathionylation, including Tdh3, Tsa1, Ssa1, Ahp1, 
Gpx1, and Srx1, were conjugated to GSH in cells treated with DVSF (Fig. 6D and E, Supp. 
Fig. 6) [15, 16, 55-57]. In addition, several putative targets for glutathionylation, including 
Rnr1 and Leu1, were cross-linked to GSH upon DVSF treatment (Supp. Fig. 6). In contrast, 
we were unable detect GSH conjugates of the glutathione peroxidases Gpx2 and Gpx3 (both 
of which undergo strong intramolecular cross-linking) or of the proteostasis factors Sse1, 
Ubc1, or Rps5 in DVSF-treated cells, indicating that certain proteins in our panel are more 
susceptible to this modification than others (Supp. Fig. 7).
We further investigated whether DVSF-mediated GSH cross-linking to Ahp1 was dependent 
on the presence of either of its catalytic cysteines. We found that GSH conjugation to Ahp1 
in DVSF-treated cells did not occur on a variant lacking the resolving cysteine (Cys31, Fig. 
6E). In contrast, strong cross-linking to GSH was observed in the wild-type protein and in 
Ahp1 variants bearing cysteine substitutions at other sites. Moreover, purified Ahp1 bearing 
an alanine substitution at Cys31 did not undergo direct S-glutathionylation and/or further 
rearrangement to form the disulfide-linked dimer when incubated with oxidized GSH 
(GSSG, Fig. 6F), unlike the other forms of Ahp1 tested. Collectively, our results indicate 
that DVSF may be used as a proxy for detecting and predicting proteins subject to regulation 
by S-glutathionylation.
Discussion
In the present study, we used the thiol-reactive, bifunctional electrophile DVSF to determine 
whether a panel of previously described oxidant targets are subject to DVSF-mediated cross-
linking. Several of the proteins screened underwent molecular weight shifts consistent with 
the formation of intermolecular cross-links (Tsa1, Tsa2, Ahp1, Mxr1, Mxr2, Ykg9, Srx1, 
Gpx1, Rnr1, and Leu1) and/or intramolecular cross-links (Mxr1, Ykg9, Gpx2, and Gpx3) 
upon treatment of cells with DVSF. Further study of a subset of these targets revealed that 
cross-linking depended upon the presence of their redox-active cysteines, many of which are 
functional cysteines used during catalysis. In investigating the potential cross-linked partners 
of candidate proteins, we found that DVSF cross-linked the cytosolic thioredoxin Trx2 to 
several of its known substrates (e.g., Tsa1, Tsa2, Ykg9, and Srx1). In other instances, DVSF 
covalently linked redox-active centers within individual proteins (e.g., Ahp1) or linked some 
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S-glutathionylation-prone proteins (e.g., Tdh3) to GSH. Collectively, our results indicate that 
DVSF has utility as a chemical tool for trapping and mapping interactions between oxidant-
sensitive network partners via irreversible modification of their oxidation-prone cysteines.
Overlapping Groups of Oxidant- and Electrophile-Sensitive Proteins
Although it has been reported that there are few commonalities between proteins undergoing 
diverse types of thiol post-translational modifications (e.g., sulfenylation, glutathionylation, 
nitrosylation, and acylation) [22], our results support a model wherein specific classes of 
oxidant- and electrophile-sensitive target proteins overlap [21, 31, 39]. In particular, the 
results of our screen indicate a prominent susceptibility of the cytosolic oxidant defense 
machinery to electrophilic modification by DVSF. Each cytosolic, thiol-dependent 
oxidoreductase involved in oxidant defense that we studied underwent a molecular weight 
shift in response to DVSF treatment, forming cross-links internally and/or with redox 
partners that function in the same network. Thus, our data support other findings wherein 
oxidant-defense enzymes that employ thiol-based mechanisms comprise a group of proteins 
targeted by alkylating agents, most likely due to the heightened reactivity of their active site 
thiols [31]. Such susceptibility of oxidant defense proteins to electrophilic modification 
commonly leads to irreversible inactivation of their function [4]. Indeed, many of these 
proteins are transcriptionally induced after exposure to electrophiles and oxidants, 
suggesting a common need for de novo versions of these proteins following thiol-targeted 
challenges [29, 58]. Moreover, the inhibition of multiple oxidant defense network proteins 
by electrophiles may account for the secondary oxidative stress component associated with 
electrophile-mediated stress [59-61]. Although many thiol-utilizing enzymes involved in 
oxidant defense are modified by both oxidants and electrophiles, further comparative work is 
needed to define more clearly the extent of overlap between electrophile- and oxidant-
sensitive proteins throughout the entire proteome.
An Irreversible Trap for Redox-Active Cysteines That Form Disulfides
A number of global studies have yielded critical insights into the redox-regulated cysteine 
proteome, pinpointing which proteins and which cysteines within them are most susceptible 
to oxidation [7]. In addition, there have been several investigations aimed at identifying the 
thioredoxin substrate pool within the cell. The latter approaches frequently rely on trapping 
intermolecular disulfides between mutated thioredoxins (i.e., enzymes that lack a resolving 
cysteine) and their interaction partners [23, 25-28]. Despite major advances in the field from 
this earlier work, several technical challenges associated with understanding cysteine-based 
redox networks in cells remain. The reversibility and rearrangement of disulfides is 
advantageous from a standpoint of redox signaling and maintaining cellular homeostasis 
[62-64]. In support of the latter point, thioredoxin-deficient yeast are slow-growing normally 
and exhibit limited survival when exposed to low levels of oxidants (Supp. Fig. 8) [65]. 
However, the dynamic nature of disulfides can complicate proteomic analysis of redox 
partnerships within individual proteins and between two proteins in biological samples. 
Indeed, many proteomic approaches aimed at studying disulfide pairs in proteins require 
considerable sample work up ex vivo, often employing a step to block free thiols and, 
therefore, prevent undesirable disulfide rearrangements [7]. In addition, the limited 
bioavailability, bulkiness, and slow reactivity of many biorthogonal oxidation traps that react 
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with cysteine sulfenic acids pose challenges in identifying oxidation-prone proteins in cells 
[30, 66, 67].
As a complement to existing approaches, we propose that DVSF may be a suitable reagent 
for studying interactions between specific cysteine residues that normally partner upon 
oxidation. DVSF is cell-permeable, has a small structure that could approximate the spatial 
constraints of a disulfide bond upon addition to thiols (unlike bulkier bifunctional agents), 
and yields cross-links within proteins over short treatment times (i.e., within one hour), 
suggesting relatively fast reactivity. Moreover, proteins cross-linked by DVSF are stable in 
the presence of standard thiol reductants, implying that they are incapable of rearrangement. 
While DVSF does not cross-link all redox partners to one another (e.g., Ahp1 to Trx2), the 
cross-linked complexes that form upon DVSF treatment may reflect a natural prioritization 
of partnerships in each of its target proteins. Thus, DVSF is of potential use in uncovering 
some, but not all, protein-based thiol partnerships in cells.
Competing Side Reactions in DVSF-Mediated Cross-Linking
One complication of our approach is that low molecular weight thiols (e.g., GSH via the 
action of GSH transferases) may react with one electrophilic center in DVSF and minimize 
intermolecular cross-linking between proteins in certain instances [68]. Indeed, many 
protein-GSH conjugates form upon DVSF treatment. GSH attachment, in one respect, 
negates the possibility of adding two different protein-derived thiols at the electrophilic 
centers in DVSF. However, such a conjugation to GSH may also be revealing about the 
ability of proteins with hyper-reactive cysteines to accommodate a GSH moiety in the site 
where DVSF is added, indicating that these proteins have the potential to be S-
glutathionylated during oxidative stress. In support of this notion, several proteins that 
undergo S-glutathionylation in yeast (e.g., Tdh3) or that have orthologs susceptible to S-
glutathionylation in other species (e.g., Ahp1, Tsa1, Ssa1) are among the proteins in which 
we observe GSH conjugation via DVSF [15, 16, 55]. Therefore, we propose that a DVSF-
mediated cross-linking approach may be useful in predicting proteins that are prone to S-
glutathionylation during oxidative stress in cells in some instances.
Applications for Using Bifunctional Electrophiles to Define Thiol Redox Networks
DVSF and other small bifunctional electrophiles cross-link proteins in a well-studied 
peroxide detoxification pathway at known sites of redox chemistry, supporting their use as 
tools in redox network biology [39-42]. The results presented herein expand these earlier 
findings and suggest a broader applicability of these reagents in studying additional redox 
partnerships, particularly in examining proteins involved in other aspects of oxidant defense. 
While our present work and earlier studies with cysteine cross-linkers have largely explored 
cross-linking reactions in established eukaryotic model systems and known redox networks, 
there are diverse, thiol-based redox homeostasis mechanisms in less-studied organisms 
wherein analytical approaches like the one we describe with DVSF may prove useful [6, 69, 
70]. Moreover, we have mainly established this approach by studying redox partnerships 
localized within the cytosol; however, related disulfide relay mechanisms exist in other 
cellular compartments in both prokaryotes (e.g., periplasmic space) and eukaryotes (e.g., 
endoplasmic reticulum, chloroplasts, and mitochondria) that have not been interrogated fully 
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[71-73]. In cases where redox interactions are poorly defined, cross-linking interacting 
proteins with DVSF or similar molecules may complement current methods for establishing 
key partnerships in thiol-based redox networks, thereby increasing our understanding of 
biological responses to oxidants during homeostasis and cellular stress.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• A thiol-reactive cross-linker (DVSF) modifies many oxidation-prone 
proteins in cells.
• DVSF traps interactions between thioredoxin and several known redox 
partners.
• DVSF can be used to probe internal cysteine redox pairs within 
proteins.
• DVSF may be used to predict proteins that undergo S-
glutathionylation.
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Figure 1. Cross-Linking of Multiple Oxidant-Sensitive Proteins in Cells Treated with DVSF
(A) Scheme of DVSF-mediated thiol cross-linking. (B) Log-phase cells expressing FLAG-
tagged forms of oxidant-sensitive proteins were treated with vehicle (DMSO) or 1 mM 
DVSF for 1 h at 30°C. Protein lysates (10-20 μg) were resolved by SDS-PAGE, transferred 
to PVDF membrane, and detected with an antibody against the FLAG-tag or Pgk1 (loading 
control) via Western blot. An asterisk (*) represents a background band that appears with the 
FLAG-antibody in certain blots. A double asterisk (**) represents a species of the protein 
that electrophoreses more quickly, suggesting intramolecular cross-linking. Results are 
representative of three independent experiments.
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Figure 2. Involvement of Redox-Active Cys Residues in Cross-Linking of DVSF Targets
Log-phase cells expressing wild-type (wt) proteins or ones with individual Cys-to-Ala 
substitutions were treated with DMSO (vehicle) or 1 mM DVSF for 1 h at 30°C. Protein 
lysates (10-20 μg) were resolved by SDS-PAGE, transferred to PVDF membrane, and 
detected with an antibody against the FLAG-tag or Pgk1 (loading control) via Western blot. 
An asterisk (*) represents a background band that appears with the FLAG-antibody in 
certain blots. A double asterisk (**) indicates potential intramolecular cross-linking in the 
protein. Results are representative of three independent experiments.
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Figure 3. Decreased Cross-Linking of DVSF Targets in Cells Pretreated with H2O2
Log-phase cells expressing DVSF targets were incubated for 10 min with either vehicle 
(H2O or DMSO) or oxidant (1 mM H2O2 or 0.5 mM TBHP, respectively) prior to treatment 
for 1 h at 30°C with DMSO (vehicle) or 1 mM DVSF. Protein lysates (10 μg) were resolved 
by SDS-PAGE, transferred to PVDF membrane, and detected with an antibody against the 
FLAG-tag or Pgk1 (loading control) via Western blot. An asterisk (*) represents a 
background band that appears with the FLAG-antibody in certain blots. Results are 
representative of three independent experiments.
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Figure 4. Cross-Linking of Selected DVSF Targets to Thioredoxin
(A) Scheme depicting cross-linking between Trx2 and its interaction partners. (B) Indicated 
proteins were expressed in wild-type (BY4741), trx1Δ trx2Δ (labeled as trxΔ) or, in the case 
of Srx1, tsa1Δ tsa2Δ (labeled as tsaΔ) cells and treated with DMSO (vehicle) or 1 mM 
DVSF for 1 h at 30°C. Protein lysates (10-20 μg) were resolved by SDS-PAGE, transferred 
to PVDF membrane, and detected with an antibody against the FLAG-tag or Pgk1 (loading 
control) via Western blot. Dots (•) represent potential intermolecular cross-links to Trx1 or 
Trx2, whereas an arrow head (<) indicates potential cross-links between Srx1 and Tsa1 or 
Tsa2. (C) FLAG-tagged proteins were co-expressed in yeast containing a TAP-tagged Trx2 
(Trx2-TAP) and treated with DMSO (vehicle) or 1 mM DVSF for 1 h at 30°C. FLAG-tagged 
proteins were immunoprecipitated from cell lysates (100 μg) and detected, along with Trx2-
TAP isolated in cross-linked complexes, via Western blot. Results are representative of three 
independent experiments.
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Figure 5. Disruption of the Redox Center at the Dimer Interface of Ahp1 Compromises Cellular 
Defense against Organic Peroxides and Impairs Cross-Linking by DVSF
(A) Structure of Ahp1 depicting catalytic Cys residues (C62 (peroxidatic Cys) and C31 
(resolving Cys)) and conserved Phe residues at the dimer interface. Protein structures were 
generated with Chimera (https://www.cgl.ucsf.edu/chimera/) using PDB 4DSR. (B) Purified 
recombinant Ahp1 (wild-type (wt) or dimer interface variants, 20 μM) were resolved on 
native-PAGE and detected with Coomassie blue to determine oligomeric state. (C) Wild-type 
(wt) or mutant forms of Ahp1 were expressed in ahp1Δ yeast. Serial dilutions of these 
cultures and corresponding controls were grown on YPD medium containing 2 mM TBHP 
for 48 h at 30°C to determine the effect of dimer interface disruption on oxidant defense. (D) 
Scheme depicting proposed inter-subunit cross-linking in Ahp1 by DVSF. (E) Purified Ahp1 
proteins (10 μM) were treated with increasing concentrations of DVSF for 3 h at 37°C, prior 
to electrophoresis on SDS-PAGE and detection by staining with Coomassie blue. (F) Log-
phase yeast cells expressing Ahp1 variants were treated with 1 mM DVSF for 1 h at 30°C. 
Protein lysates (10-20 μg) were resolved by SDS-PAGE, transferred to PVDF membrane, 
and detected with an antibody against the FLAG-tag or Pgk1 (loading control) via Western 
blot. Results for all experiments are representative of three independent trials.
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Figure 6. Cross-Linking of GSH to Redox-Active Proteins in Cells Treated with DVSF
(A) Scheme depicting GSH cross-linking to putative DVSF targets. (B) Log-phase yeast 
cells (BY4741) were treated with increasing doses of DVSF for 1 h at 30°C. Protein lysates 
(10 μg) were resolved by SDS-PAGE, transferred to PVDF membrane, and detected with an 
antibody against the FLAG-tag or Pgk1 (loading control) via Western blot. (C) Log-phase 
yeast cells (BY4741 or gsh1Δ) were treated with 1 mM DVSF for 1 h at 30°C. Protein 
lysates (10 μg) were resolved by SDS-PAGE, transferred to PVDF membrane, and detected 
with an antibody against the FLAG-tag or Pgk1 (loading control) via Western blot. (D and 
E) Cells expressing FLAG-tagged proteins were treated with 1 mM DVSF for 1 h at 30°C. 
FLAG-tagged proteins were immunoprecipitated from cell lysates (100 μg). Western blots 
were conducted to determine isolation of FLAG-tagged protein and its conjugation to GSH. 
Arrows point to protein-glutathione conjugates. (F) Purified Ahp1 variants (10 μM) were 
incubated with varying concentrations of GSSG for 20 min, prior to alkylation of free 
cysteines with N-ethylmaleimide and resolution by non-reducing SDS-PAGE. S-
glutathionylation was monitored by Western blot. Ahp1 levels and oxidation were visualized 
with Coomassie blue. Results are representative of two-three independent experiments.
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